PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,193 stories, page 494 of 704

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

NKGen Biotech (NKGN) alters collateral on $5M credit facility

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) cancels erroneous stock option grant

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) amends Form 4 to cancel option grant

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) director corrects erroneous, cancelled option grant

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

"Give time to comply": Shiv Sena's Sanjay Nirupam on FDA's milk packaging norms

indiagazette.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Health Headlines: Challenges, Outbreaks, and Innovations

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Thousands of Bottles of Prescription Antihistamine Recalled, FDA Notice Says

NTD NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Experts: Ending adequate provision would shut down prescription drug ads

RAPSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk to launch lower-cost Ozempic copy in South Africa

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Challenges, & Solutions to the Domestic Pharma Production Shift

Powder & Bulk SolidsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Florida Biotech Firm Takes FDA to Court Over Biden Era Export Delays

Floridian PressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Accenture (ACN) Secures Defense Contract for Pharmaceutical Solu

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

markets.businessinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Former Biotech Executive Erica Bazerkanian Announces 2026 Strategic Expansion of DTC Apparel Brand Bold&Zeal

markets.businessinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Expert Insights: Psychedelics, Cannabis, Drug Policy Shift

Mirage NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zentalis' Azenosertib Accepted for Rapid ESMO Survival Presentation

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sellas Life (SLS) Climbs 12% Ahead of ‘Potentially Company-Defining’ Clinical Trial Result

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DNTH Stock Pops As Phase 3 EMERGE Trial Kicks Off

StocksToTradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mass. biotech: FDA to review experimental cancer drug after two rejections, 200+ layoffs

MassLiveOriginal source
🌍discoverynews.google.comTier 2 · Trade media

GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Some telehealth GLP-1 prescriptions have little clinician oversight, little regulation

Healthcare BrewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since December 2024 -- Data Talk

MoomooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

2025 BIG Executive Summit: Supported Funding Models for Biotech

BioProcess InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Incyte: Profitable Biotech That Could Be Close To Exploding (NASDAQ:INCY)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ask an Expert: Psychedelics, cannabis, GLP-1s and drug policy changes

The Pennsylvania State UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

‘We Are Not Defending What Biden Did’: Blanche Answers Hawley On Abortion Pills

tippinsightsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pilot program to boost biotech manufacturing careers

Insight NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA raids two PMC hospitals over unsafe drug dispensing; suspends 10 licences of eateries, bakeries and d

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North Carolina receives $29.6 million settlement in pharmaceutical price-fixing conspiracy

YahooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Should stem cell therapies be regulated as drugs? This biotech company is taking the FDA to court.

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This Biotech Company Has Spent Nearly 3 Years in FDA Limbo

Reason MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Gates Medical Research Institute & Serum Institute of India to manufacture new TB vaccine candidate

BioSpectrum IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UK Biotech Completes Cancer-Focused Co. Buy In £17M Deal

Law360Original source
🌍discoverynews.google.comTier 3 · Aggregated media

$1B Swiss biotech establishes US headquarters in the Queen City

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 36.2% in June

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Langham Logistics leans into pharmaceutical cold storage

Indianapolis Business JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Serum Institute to manufacture potential first TB vaccine in over 100 years under Gates MRI deal

Northeast HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline

Bloomberg.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oramed stock trades quietly as diabetes pill strategy pivots after FDA setback

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. Senators Look to Investigate Foreign Influence on U.S. Pharmaceutical Supply Chains

NAVLIN DAILYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ASU, Callan JMB Partnership Poised to Transform Marion into National Pharmaceutical Hub

Alabama State UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Supply Chain Signal: Domestic Manufacturing and the German Pricing Standoff

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves first cholesterol pill to match powerful injectable drugs

YnetnewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lifera leads Saudi Arabia's push to become global biotech hub

BioProcess InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Grants Traditional Approval to Novartis's Fabhalta | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kibow® Biotech Honored with The American Association of Naturopathic Physicians Corporation of the Year Award

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GSK shelves cough therapy added from $2B Bellus buyout after trial failure

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. Biotech Sector Must Reject MFN to Beat China: Expert Op-ed

NAVLIN DAILYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nuvation Bio Moves Safusidenib Into Phase 3, Raising Stakes in Targeted Brain Cancer

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Where To Invest Now In AI, Biotech, Small Caps, And Gold

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Form 144 COLLEGIUM PHARMACEUTICAL For: 17 July By Investing.com

Investing.com CanadaOriginal source
🌍Regulatorywho.intTier 1 · Regulatory source

Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda

WHO Disease Outbreak NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BRIGHT PATH CONGRATULATES KHONA SCIENTIFIC'S INVESTMENT In STRENGTHENING AMERICA'S PHARMACEUTICAL SUPPLY CHAIN

EIN NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BlossomHill eyes IPO to grow taller in crowded cancer fields

Fierce BiotechOriginal source